Halotherapy for Children With Asthma: Safety and Outcomes

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Halotherapy involves inhaling fine salt particles, which may help improve breathing in some respiratory conditions. A 2015 pilot study noted halotherapy improved clinical symptoms in children with mild to moderate asthma after 12 sessions.
Research in 2000 showed halotherapy corrected free-radical oxidation and improved local immunity in patients with chronic bronchitis.
The Asthma and Allergy Foundation of America states that more research is needed to determine halotherapy's effectiveness for asthma.
A study titled "Effect of Halotherapy in Children With Asthma" is currently registered on ClinicalTrials.gov with identifier NCT06250452.

Halotherapy, often called salt therapy, is a natural treatment that involves breathing in fine salt particles in a controlled environment. This approach is explored for its potential to help with various respiratory issues, including asthma in children. While some preliminary studies show promise, experts highlight the need for more extensive research to fully understand its safety and effectiveness. For example, a 2015 pilot study indicated that children with mild to moderate asthma saw improved clinical symptoms after completing 12 sessions of halotherapy [https://pubmed.ncbi.nlm.nih.gov/27723955/]. However, the Asthma and Allergy Foundation of America (AAFA) emphasizes that more evidence is needed to confirm its widespread benefit for asthma patients [https://community.aafa.org/blog/aafa-explains-is-therapy-safe-and-effective-for-asthma?postsPerPage=20&sort=oldest]. The scientific community continues to investigate, with ongoing clinical trials, such as the "Effect of Halotherapy in Children With Asthma" study registered on ClinicalTrials.gov with identifier NCT06250452 [https://clinicaltrials.gov/study/NCT06250452], aiming to provide clearer answers regarding its role in pediatric asthma management.

What is Halotherapy and How Does it Work?

Halotherapy is a natural wellness practice where individuals breathe in microscopic salt particles within a specially designed room. These salt rooms, often called salt caves, create a dry, sterile, and salt-enriched microclimate. The core idea behind halotherapy is that inhaling these tiny salt particles can benefit the respiratory system. The salt is thought to act as an anti-inflammatory and antibacterial agent, helping to clear mucus, reduce inflammation in the airways, and potentially improve overall respiratory function. This therapy has been studied for various respiratory conditions, including chronic bronchitis, and its potential mechanisms are rooted in the properties of salt itself.

The Science Behind Salt Inhalation

When the fine salt particles are inhaled, they travel deep into the lungs and airways. Here, the salt is believed to absorb toxins and allergens from the respiratory system. It also has mucolytic properties, meaning it helps to thin mucus, making it easier to cough up and expel from the body. This can be particularly beneficial for conditions where mucus buildup is a significant problem, such as asthma or chronic bronchitis. The salt's anti-inflammatory properties may also help to calm irritated airways, reducing swelling and making breathing easier.

Historical Context and Modern Application

The concept of using salt for health benefits dates back centuries, with observations made in salt mines where workers reportedly had fewer respiratory problems. Modern halotherapy recreates these natural salt cave environments using a device called a halogenerator. This machine grinds pharmaceutical-grade salt into tiny particles and disperses them into the air, maintaining a consistent concentration, temperature, and humidity. This controlled environment ensures that the therapy is delivered effectively and consistently.

Evidence from Chronic Bronchitis Studies

While our focus is on asthma, understanding halotherapy's effects on other respiratory conditions can shed light on its potential mechanisms. A 2000 study involving 49 patients with lingering inflammatory chronic bronchitis provided insights into how halotherapy might work. The chemoluminescence test in these patients initially revealed an inhibition of active oxygen forms in the whole blood, an intensification of lipid peroxidation in the serum, and a depression of local immunity. The administration of halotherapy to these patients led to a correction of disturbances of free-radical oxidation, improved local immunity, and an improved clinical course of the disease [https://pubmed.ncbi.nlm.nih.gov/11197648/]. This suggests that halotherapy can influence immune responses and reduce oxidative stress, which are factors often involved in chronic respiratory conditions. This research indicates that halotherapy can have measurable physiological effects on the body's immune and anti-oxidant systems.

Addressing Inflammation and Immunity

Inflammation is a hallmark of many respiratory diseases, including asthma. By potentially reducing inflammation, halotherapy could alleviate symptoms like wheezing, coughing, and shortness of breath. The improvement in local immunity observed in the chronic bronchitis study is also significant. A stronger local immune response in the respiratory tract could help the body fight off infections and reduce the frequency and severity of exacerbations. This dual action—reducing inflammation and boosting immunity—is a key area of interest for researchers investigating halotherapy's broader applications in respiratory wellness. Further studies are needed to see if these benefits translate directly and consistently to children with asthma, but the initial findings provide a foundation for understanding the therapy's potential.

Is Halotherapy Safe for Children with Asthma?

The safety of any new treatment for children, especially those with chronic conditions like asthma, is a top priority for parents and healthcare professionals. Halotherapy is generally considered non-invasive and drug-free, which can make it an appealing option for some families. However, the scientific community continues to investigate its safety and effectiveness specifically for pediatric asthma. While some pilot studies have explored its use in younger populations, ongoing research aims to provide more definitive answers on both the safety profile and the efficacy of halotherapy for children.

Understanding the Safety Profile

Halotherapy involves breathing in dry salt aerosol, which is different from nebulized saline solutions. The salt particles are very fine, allowing them to reach deep into the respiratory system. For children with asthma, concerns might include potential irritation of sensitive airways or interactions with existing asthma medications. However, studies often highlight that halotherapy is generally well-tolerated. A randomized, controlled, prospective pilot study conducted in 2015 specifically investigated halotherapy as an asthma treatment in children [https://pubmed.ncbi.nlm.nih.gov/27723955/]. This type of study design is crucial for assessing both safety and early indicators of effectiveness in a controlled manner.

Considerations for Pediatric Patients

Children's respiratory systems are still developing, and their airways can be more reactive than those of adults. Therefore, any therapy introduced needs careful consideration. Halotherapy sessions are typically conducted in a calm, controlled environment, which can also be a positive experience for children. The concentration of salt aerosol is carefully regulated to ensure it is appropriate for therapeutic use. Parents should always discuss halotherapy with their child's pediatrician or asthma specialist before starting any sessions, especially to ensure it complements their existing asthma management plan and does not interfere with prescribed medications. For more details, see Halotherapy for treatment of respiratory diseases.

The Role of Ongoing Research

The medical community emphasizes the need for more rigorous, large-scale studies to confirm the long-term safety and efficacy of halotherapy for children with asthma. While pilot studies provide initial insights, they are often limited by sample size and duration. The Asthma and Allergy Foundation of America (AAFA) has stated that more research is needed to determine halotherapy's effectiveness for asthma [https://community.aafa.org/blog/aafa-explains-is-therapy-safe-and-effective-for-asthma?postsPerPage=20&sort=oldest]. This ongoing pursuit of evidence is critical to establishing halotherapy as a recognized and recommended treatment option. Clinical trials are designed to gather comprehensive data on potential side effects, optimal dosing (session length and frequency), and long-term outcomes, which are all vital for pediatric applications.

Addressing Concerns and Misconceptions

One common misconception is that halotherapy replaces conventional asthma treatments. Healthcare providers consistently advise that halotherapy should be considered an adjunctive therapy, meaning it is used alongside, not instead of, prescribed medications and medical advice. Children with asthma should continue to use their inhalers and other medications as directed by their doctor. The goal of complementary therapies like halotherapy is often to potentially reduce symptom frequency or severity, thereby improving quality of life, but not to cure the underlying condition or replace life-saving medications. Ensuring that parents and guardians are well-informed about the current evidence and the role of halotherapy in a comprehensive treatment plan is essential for safe implementation.

What Have Studies Shown About Halotherapy Outcomes for Children with Asthma?

Clinical studies have explored how halotherapy impacts symptoms and lung function in children diagnosed with asthma. The results from these investigations provide an initial glimpse into the potential benefits of this therapy, though researchers consistently highlight the need for more robust and extensive studies. Various metrics are used to assess outcomes, ranging from subjective reports of symptom improvement to objective measures like lung function tests.

Early Indications from Pilot Studies

One significant finding comes from a 2015 pilot study that focused on halotherapy as an asthma treatment in children. This study indicated that children with mild to moderate asthma experienced improved clinical symptoms after completing a course of 12 halotherapy sessions [https://pubmed.ncbi.nlm.nih.gov/27723955/]. Clinical symptoms can include factors such as coughing, wheezing, shortness of breath, and overall discomfort related to asthma. Improvements in these areas suggest a potential benefit for the children receiving the therapy. However, as a pilot study, its findings are considered preliminary and call for larger-scale replication.

Examining Lung Function with Objective Measures

Beyond subjective symptom reports, researchers also look at objective measures to assess the effectiveness of treatments. Peak expiratory flow (PEF) is a common objective measure that indicates how fast a person can exhale air from their lungs. This measurement is crucial for monitoring asthma control. A randomized crossover trial conducted in 2017 specifically examined the effect of salt space, another term for halotherapy, on clinical findings and peak expiratory flow in children with mild to moderate asthma [https://pubmed.ncbi.nlm.nih.gov/28732433/]. This type of study design allows researchers to compare the effects of the therapy within the same group of participants, providing valuable data on its impact on lung function. While the specific outcomes of this trial would require a detailed review of its full publication, the fact that such objective measures are being studied demonstrates a commitment to scientifically evaluating halotherapy's impact.

Variability in Research Findings

It is important to acknowledge that results from different studies can vary. Factors such as the severity of asthma, the specific halotherapy protocol used (e.g., duration and frequency of sessions, salt concentration), and the age of the children involved can all influence outcomes. The scientific process often involves accumulating evidence from multiple studies to draw more confident conclusions. This variability underscores why organizations like the Asthma and Allergy Foundation of America emphasize the need for more research. Researchers are working to identify which specific patient populations might benefit most from halotherapy and under what conditions.

The Importance of Controlled Trials

Randomized controlled trials (RCTs) are considered the gold standard in medical research because they minimize bias and provide the strongest evidence of a treatment's effectiveness. The pilot study in 2015 and the crossover trial in 2017 are examples of controlled research designs that contribute to our understanding of halotherapy. These studies compare outcomes in groups receiving halotherapy against control groups, which might receive a placebo or standard care. By using such rigorous methods, researchers can better ascertain whether observed improvements are truly due to the halotherapy itself or other factors. The ongoing nature of this research means that our understanding of halotherapy's role in pediatric asthma treatment is continually evolving.

How Does Halotherapy Impact Lung Function and Immunity?

Halotherapy is believed to influence the respiratory system in several key ways, primarily impacting lung function and the body's immune response. The inhalation of fine salt particles is thought to create a beneficial environment within the airways, helping to clear blockages and reduce inflammation. These effects can, in turn, contribute to improved breathing and a more robust defense against respiratory pathogens.

Enhancing Mucus Clearance and Reducing Inflammation

One of the primary mechanisms attributed to halotherapy is its ability to help clear mucus from the airways. The microscopic salt particles are believed to draw moisture into the respiratory tract, thinning the mucus and making it easier for the body's cilia (tiny hair-like structures that line the airways) to move it out. This mucolytic effect is crucial for individuals with asthma, where thick, sticky mucus can obstruct airways and contribute to breathing difficulties. Additionally, salt is known for its anti-inflammatory properties. When inhaled, the salt particles may help reduce swelling and irritation in the bronchial tubes, which are characteristic features of asthma. A reduction in inflammation can lead to wider airways and easier breathing. For more details, see Halotherapy as asthma treatment in children: A randomized, controlled, prospective pilot study.

Modulating the Immune System

Beyond its direct effects on mucus and inflammation, halotherapy has also been investigated for its influence on the immune system, particularly local immunity within the respiratory tract. The immune system plays a critical role in how the body responds to allergens, irritants, and infections that can trigger asthma symptoms. Research from 2000, focusing on chronic bronchitis patients, provided significant insights into this aspect. The study found that halotherapy corrected disturbances of free-radical oxidation and improved local immunity in 49 patients with chronic bronchitis [https://pubmed.ncbi.nlm.nih.gov/11197648/]. Free-radical oxidation refers to a process where unstable molecules can damage cells, and its correction suggests an antioxidant effect of the therapy. Improved local immunity means the body's defenses within the respiratory passages are strengthened, potentially making it more resilient against environmental triggers and infections.

Correcting Free-Radical Oxidation

The finding that halotherapy can correct disturbances of free-radical oxidation is an important one. Oxidative stress, caused by an imbalance between free radicals and antioxidants, is implicated in the pathology of various chronic diseases, including asthma. By helping to restore this balance, halotherapy might reduce cellular damage in the lungs and contribute to a healthier respiratory environment. "The chemoluminescence test in 49 patients with lingering inflammatory chronic bronchitis has revealed inhibition of generation of active oxygen forms in the whole blood, intensification of lipid peroxidation in the serum, depression of local immunity. Administration of halotherapy to the above patients results in correction of disturbances of free-radical oxidation, improves local immunity and clinical course of the disease," stated L M Abdrakhmanova et al. in Vopr Kurortol Fizioter Lech Fiz Kult. 2000 Nov-Dec. This quote highlights the physiological changes observed at a cellular level following halotherapy.

Overall Impact on Respiratory Wellness

The combined effects of enhanced mucus clearance, reduced inflammation, improved local immunity, and corrected oxidative balance suggest that halotherapy could contribute to overall respiratory wellness. For children with asthma, these impacts could translate into fewer asthma attacks, reduced reliance on rescue medications, and a better quality of life. However, it is crucial to remember that these are potential benefits and more targeted research on children with asthma is needed to fully confirm these mechanisms and their clinical significance. The research on chronic bronchitis provides a strong foundation for understanding the biological pathways that halotherapy might influence, paving the way for further investigation into its applications for asthma.

What Do Major Health Organizations Say About Halotherapy for Asthma?

Major health organizations play a crucial role in guiding patients and healthcare providers on the efficacy and safety of various treatments, including complementary therapies like halotherapy. Their perspectives are often based on a comprehensive review of available scientific evidence and help to establish standards for care. For asthma, these organizations typically emphasize evidence-based treatments that have undergone rigorous testing.

The Stance of the Asthma and Allergy Foundation of America (AAFA)

The Asthma and Allergy Foundation of America (AAFA) is a leading patient advocacy organization for people with asthma and allergies. When it comes to therapies like halotherapy, the AAFA adopts a cautious, evidence-based approach. The organization states clearly that more research is needed to determine halotherapy's effectiveness for asthma [https://community.aafa.org/blog/aafa-explains-is-therapy-safe-and-effective-for-asthma?postsPerPage=20&sort=oldest]. This position reflects the current state of scientific literature, which, while showing some promising pilot studies, lacks the large-scale, long-term randomized controlled trials typically required to recommend a treatment widely.

Importance of Evidence-Based Medicine

Health organizations prioritize treatments that have demonstrated clear benefits and safety through robust clinical trials. This is especially important for chronic conditions like asthma, which can significantly impact a child's health and quality of life. The AAFA's stance encourages patients and practitioners to rely on therapies with established efficacy, while also acknowledging the potential for new treatments to emerge with further research. They stress that unproven therapies should not replace conventional, doctor-prescribed asthma management plans. Instead, if considered, they should be discussed with a healthcare provider to ensure they do not interfere with existing treatments or pose any risks.

Guiding Patients and Healthcare Providers

The guidance from organizations like the AAFA is vital for informing the public. It helps patients make educated decisions about their health and helps healthcare providers offer the best possible advice. When an organization states that more research is needed, it signals that while a therapy might have some theoretical basis or preliminary positive results, there isn't enough conclusive evidence yet to fully endorse it as a standard treatment. This also serves as a call to action for the scientific community to conduct the necessary studies to either confirm or refute the claims made about such therapies.

The Broader Context of Complementary Therapies

Halotherapy falls under the umbrella of complementary and alternative medicine (CAM). Many health organizations advise caution when exploring CAM therapies, recommending that patients always keep their primary healthcare team informed. This is to ensure coordinated care and to prevent potential harm from unverified treatments. The AAFA's position on halotherapy is consistent with this general approach, advocating for patient safety and the use of treatments supported by strong scientific evidence. As the research base for halotherapy continues to grow, these organizations will likely update their recommendations accordingly. Until then, the message remains clear: while promising, more definitive studies are required to fully understand halotherapy's role in asthma management.

Are There Ongoing Clinical Trials for Halotherapy in Children with Asthma?

The scientific community is actively engaged in exploring the potential benefits and safety of halotherapy, particularly for children with asthma. This ongoing commitment to research is crucial for building a comprehensive evidence base that can inform future medical recommendations. New studies are continuously being registered to investigate various aspects of halotherapy, including its effects on specific patient populations and the optimal protocols for its application. For more details, see AAFA Explains: Is Salt Therapy Safe and Effective for Asthma?.

The Role of Clinical Trial Registries

Clinical trial registries, such as ClinicalTrials.gov, serve as vital public databases for information about ongoing and completed research studies worldwide. These registries provide transparency and allow anyone to track the progress of medical investigations. They contain details about study design, participant eligibility, interventions being tested, and expected outcomes. For halotherapy in children with asthma, these registries offer a snapshot of the current research landscape.

A Glimpse into Current Research

Indeed, a study titled "Effect of Halotherapy in Children With Asthma" is currently registered on ClinicalTrials.gov. The identifier for this specific study is NCT06250452 [https://clinicaltrials.gov/study/NCT06250452]. The presence of such a registration indicates that researchers are actively working to gather more data on how halotherapy might impact children diagnosed with asthma. This particular trial, like many others, aims to contribute to our understanding by collecting specific information on its effects.

Objectives of New Trials

These ongoing trials typically aim to achieve several key objectives. They seek to:

Evaluate Efficacy: Determine if halotherapy can lead to measurable improvements in asthma symptoms, lung function (e.g., peak expiratory flow, forced expiratory volume), or quality of life for children with asthma.
Assess Safety: Monitor for any adverse effects or safety concerns associated with halotherapy in a pediatric population. This is critical for ensuring the therapy is well-tolerated.
Optimize Protocols: Investigate different treatment parameters, such as the number of sessions, duration of each session, and salt concentration, to identify the most effective and safe protocols.
Understand Mechanisms: Further explore the biological mechanisms through which halotherapy might exert its effects, building on prior research that showed impacts on local immunity and free-radical oxidation in other respiratory conditions.

The Importance of Future Research

The registration of new clinical trials is a positive sign for the field of halotherapy research. It signifies a continued effort to move beyond pilot studies and anecdotal evidence towards more robust, evidence-based conclusions. For parents and healthcare providers seeking definitive answers about halotherapy for children with asthma, these ongoing studies represent the path forward. Their findings will be instrumental in shaping future guidelines and recommendations for its use. Until the results of these and other comprehensive studies are published and peer-reviewed, the medical community will continue to advocate for caution and adherence to established asthma management plans. The data collected from trials like NCT06250452 will be crucial in determining the long-term role of halotherapy in pediatric respiratory wellness.

Frequently Asked Questions

What is halotherapy?

Halotherapy is a natural wellness practice that involves breathing in fine, dry salt particles in a controlled environment, often called a salt room or salt cave. The salt is typically pharmaceutical-grade sodium chloride, ground into microscopic particles by a device called a halogenerator. The therapy is believed to help clear mucus, reduce inflammation, and improve respiratory function by acting as an anti-inflammatory and antibacterial agent in the airways. A 2000 study showed that halotherapy administration improved local immunity and the clinical course of chronic bronchitis in 49 patients [https://pubmed.ncbi.nlm.nih.gov/11197648/].

Is halotherapy effective for children with asthma?

Preliminary studies suggest potential benefits, but major health organizations indicate that more research is needed to confirm its effectiveness for children with asthma. A 2015 pilot study indicated that halotherapy improved clinical symptoms in children with mild to moderate asthma after 12 sessions [https://pubmed.ncbi.nlm.nih.gov/27723955/]. However, the Asthma and Allergy Foundation of America states that more research is needed to determine halotherapy's effectiveness for asthma [https://community.aafa.org/blog/aafa-explains-is-therapy-safe-and-effective-for-asthma?postsPerPage=20&sort=oldest].

Are there any risks for children using halotherapy?

Halotherapy is generally considered non-invasive and safe, but parents should consult a pediatrician or asthma specialist before starting any new treatment for their child. While side effects are rare, some individuals might experience mild throat irritation or coughing as mucus begins to loosen. There are no known serious risks associated with properly administered halotherapy. A randomized, controlled, prospective pilot study in 2015 investigated halotherapy as an asthma treatment in children, with safety being a key aspect of such research [https://pubmed.ncbi.nlm.nih.gov/27723955/].

How many halotherapy sessions are typically recommended?

The number of recommended halotherapy sessions can vary depending on the individual's condition and the specific protocol. For chronic conditions like asthma, sessions are often suggested in a series over a period. For example, a 2015 pilot study that observed improved clinical symptoms in children with mild to moderate asthma involved 12 halotherapy sessions [https://pubmed.ncbi.nlm.nih.gov/27723955/]. It is always best to follow the guidance of a qualified practitioner and your child's healthcare provider.

Where can I find more information about halotherapy research?

Information about halotherapy research can be found on reputable scientific databases and clinical trial registries. PubMed is an excellent resource for published medical studies, and ClinicalTrials.gov lists ongoing research. For instance, a study titled "Effect of Halotherapy in Children With Asthma" is currently registered on ClinicalTrials.gov with identifier NCT06250452 [https://clinicaltrials.gov/study/NCT06250452]. Reviewing these sources can provide access to the latest scientific findings.